Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Diego José Laderach"'
Autor:
Diego José Laderach, Daniel Compagno
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
Galectins play relevant roles in tumor development, progression and metastasis. Accordingly, galectins are certainly enticing targets for medical intervention in cancer. To date, however, clinical trials based on galectin inhibitors reported inconclu
Externí odkaz:
https://doaj.org/article/dd72482dda814bbfa33a1915b940874d
Autor:
Carolina Tiraboschi, Lucas Gentilini, Carla Velazquez, Enrique Corapi, Felipe Martín Jaworski, José Daniel Garcia Garcia, Yorfer Rondón, Anne Chauchereau, Diego José Laderach, Daniel Compagno
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Prostate cancer (PCa) is a major health problem worldwide. Taxol derivatives-based chemotherapies or immunotherapies are usually proposed depending on the symptomatic status of the patient. In the case of immunotherapy, tumors develop robu
Externí odkaz:
https://doaj.org/article/b1a710280c5e4d87a939e4560531c1c8
Autor:
Daniel Compagno, Carolina Tiraboschi, José Daniel Garcia, Yorfer Rondón, Enrique Corapi, Carla Velazquez, Diego José Laderach
Publikováno v:
Biomolecules, Vol 10, Iss 5, p 750 (2020)
Galectins are small proteins with pleiotropic functions, which depend on both their lectin (glycan recognition) and non-lectin (recognition of other biomolecules besides glycans) interactions. Currently, 15 members of this family have been described
Externí odkaz:
https://doaj.org/article/b195a4ca5a554678840d5600faf277d6